Last reviewed · How we verify

Topical Dapsone 5% Gel

Memorial Sloan Kettering Cancer Center · Phase 3 active Small molecule

Topical dapsone reduces inflammation and bacterial colonization in skin lesions through its antimicrobial and anti-inflammatory properties.

Topical dapsone reduces inflammation and bacterial colonization in skin lesions through its antimicrobial and anti-inflammatory properties. Used for Acne vulgaris, Rosacea, Other inflammatory skin conditions.

At a glance

Generic nameTopical Dapsone 5% Gel
SponsorMemorial Sloan Kettering Cancer Center
Drug classSulfone antimicrobial
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

Dapsone is a sulfone antimicrobial agent that inhibits bacterial folate synthesis and possesses immunomodulatory effects that reduce neutrophilic inflammation. When formulated as a topical 5% gel, it delivers the drug directly to affected skin areas, minimizing systemic exposure while treating localized inflammatory and infectious skin conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results